Feasibility and Acceptability of an Internet-based Cognitive-behavioral Treatment for Insomnia in Adults With Asthma
Not Applicable
Completed
- Conditions
- AsthmaInsomnia Chronic
- Registration Number
- NCT03002402
- Lead Sponsor
- University of Pittsburgh
- Brief Summary
The purpose of the proposed study are to explore changes in sleep and asthma outcomes from baseline to post-treatment in adults with asthma and comorbid insomnia who underwent Internet-based cognitive-behavioral treatment for insomnia (CBT-I).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
- Primary diagnosis of moderate-severe persistent asthma
- Not well controlled asthma (score ≤ 19 on the Asthma Control Test)
- Age 18-75 years
- Meets criteria for Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Insomnia Disorder
- At least moderate insomnia severity (score ≥ 10 on Insomnia Severity Index)
- Telephone number, email address, and reliable Internet access
Exclusion Criteria
- History of bipolar or psychosis
- Substance abuse disorder within past 3 months
- Dementia or probable dementia diagnosis
- Plans to move or leave present source of care during the following 6 months.
- Non-English speaking, illiterate, or possesses sensory deficits
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Asthma control baseline and post-intervention (up to 9 weeks) Asthma Control Test
Insomnia severity baseline and post-intervention (up to 9 weeks) Insomnia Severity Index
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link insomnia and asthma exacerbation in CBT-I studies?
How does internet-based CBT-I compare to in-person CBT-I for insomnia in asthma patients?
Are there specific biomarkers that predict response to CBT-I in adults with comorbid asthma and insomnia?
What are the potential adverse events associated with CBT-I in patients with chronic obstructive pulmonary disease and insomnia?
How do combination therapies of CBT-I and pharmacological agents affect insomnia and asthma outcomes?
Trial Locations
- Locations (1)
University of Pittsburgh
🇺🇸Pittsburgh, Pennsylvania, United States
University of Pittsburgh🇺🇸Pittsburgh, Pennsylvania, United States